Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Clinical trial NCT00894504 · COMPLETED

Trial details

NCT number: NCT00894504
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2010-02-01
Primary completion: 2014-09-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.